Drug Designing Methods Based on Structure
Received Date: Oct 24, 2022 / Accepted Date: Nov 16, 2022 / Published Date: Nov 21, 2022
Abstract
In recent years, there have been numerous breakthroughs in the fast expanding field of structure-based medication design. Numerous novel targets and chances for the development of therapeutic leads have been made possible by the explosion of genomic, proteomic, and structural information. This article provides an overview of the structure-based drug design process, focusing largely on the selection of a target, assessment of the target's
structural characteristics, key considerations to think about when selecting a method for drug lead discovery, and assessment of the drug leads. An analysis of drug design for AmpC -lactamase will serve as an example of key concepts in the field of structure-based drug design.
Citation: Ranjan A (2022) Drug Designing Methods Based on Structure. J Mol Pharm Org Process Res 10: 154.
Copyright: © 2022 Ranjan A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Open Access Journals
Article Usage
- Total views: 525
- [From(publication date): 0-2022 - Apr 28, 2024]
- Breakdown by view type
- HTML page views: 366
- PDF downloads: 159
